113 related articles for article (PubMed ID: 8258114)
1. Treating carcinomatous pleural effusion by intrapleural injection of OK-432 in patients with non-small-cell lung cancer.
Chao TY; Hwang WS
Zhonghua Yi Xue Za Zhi (Taipei); 1993 Oct; 52(4):229-34. PubMed ID: 8258114
[TBL] [Abstract][Full Text] [Related]
2. Randomized phase II trial of OK-432 in patients with malignant pleural effusion due to non-small cell lung cancer.
Kasahara K; Shibata K; Shintani H; Iwasa K; Sone T; Kimura H; Nobata K; Hirose T; Yoshimi Y; Katayama N; Ishiura Y; Kita T; Nishi K; Nakatsumi Y; Ryoma Y; Fujimura M; Nakao S
Anticancer Res; 2006; 26(2B):1495-9. PubMed ID: 16619563
[TBL] [Abstract][Full Text] [Related]
3. Randomized phase II trial of three intrapleural therapy regimens for the management of malignant pleural effusion in previously untreated non-small cell lung cancer: JCOG 9515.
Yoshida K; Sugiura T; Takifuji N; Kawahara M; Matsui K; Kudoh S; Takada M; Fukuoka M; Ariyoshi Y; Fukuda H; Saijo N
Lung Cancer; 2007 Dec; 58(3):362-8. PubMed ID: 17716779
[TBL] [Abstract][Full Text] [Related]
4. Comparison of OK-432 and mitomycin C pleurodesis for malignant pleural effusion caused by lung cancer. A randomized trial.
Luh KT; Yang PC; Kuo SH; Chang DB; Yu CJ; Lee LN
Cancer; 1992 Feb; 69(3):674-9. PubMed ID: 1309678
[TBL] [Abstract][Full Text] [Related]
5. [Comparison of intrapleural OK-432 and cisplatin for malignant pleural effusion in lung cancer patients].
Shimizu T; Takahashi N; Terakado M; Sato M; Sugane T; Kisohara A; Akusawa H; Tsujino I; Horie T
Gan To Kagaku Ryoho; 2005 Aug; 32(8):1139-43. PubMed ID: 16121916
[TBL] [Abstract][Full Text] [Related]
6. Influence of lymphocytes in malignant pleural effusion on the therapeutic efficacy of intrapleural OK-432 in lung cancer patients.
Shimizu T; Takahashi N; Terakado M; Akusawa H; Tsujino I; Horie T
Intern Med; 2006; 45(11):715-20. PubMed ID: 16819251
[TBL] [Abstract][Full Text] [Related]
7. Interferon-alpha in serum and carcinomatous pleural effusion after repeated intrapleural injections of antitumor agents.
Kaneto E; Sasaki H; Tamura I; Kurimura O; Kurimura T
Biken J; 1983 Jun; 26(2):99-102. PubMed ID: 6318725
[TBL] [Abstract][Full Text] [Related]
8. [Intrathoracic infusion with a combination of low-dose minocycline, OK-432 and cisplatin for malignant pleural effusion].
Ishimori S; Okada S; Yamagata S; Satoh S
Gan To Kagaku Ryoho; 2005 Mar; 32(3):345-9. PubMed ID: 15791817
[TBL] [Abstract][Full Text] [Related]
9. Intrapleural cisplatin and OK432 therapy for malignant pleural effusion caused by non-small cell lung cancer.
Ishida A; Miyazawa T; Miyazu Y; Iwamoto Y; Zaima M; Kanoh K; Sumiyoshi H; Doi M
Respirology; 2006 Jan; 11(1):90-7. PubMed ID: 16423208
[TBL] [Abstract][Full Text] [Related]
10. Intrapleural combination therapy with bevacizumab and cisplatin for non-small cell lung cancer‑mediated malignant pleural effusion.
Du N; Li X; Li F; Zhao H; Fan Z; Ma J; Fu Y; Kang H
Oncol Rep; 2013 Jun; 29(6):2332-40. PubMed ID: 23525453
[TBL] [Abstract][Full Text] [Related]
11. Modified intrapleural cisplatin treatment for lung cancer with positive pleural lavage cytology or malignant effusion.
Muraoka M; Oka T; Akamine S; Tagawa T; Morinaga M; Inoue M; Yamayoshi T; Hashizume S; Matsumoto K; Hayashi T; Nagayasu T
J Surg Oncol; 2006 Mar; 93(4):323-9. PubMed ID: 16496367
[TBL] [Abstract][Full Text] [Related]
12. Effect of medical thoracoscopy-guided intrapleural docetaxel therapy to manage malignant pleural effusion in patients with non-small cell lung cancer: A pilot study.
Choi MG; Park S; Oh DK; Kim HR; Lee GD; Lee JC; Choi CM; Ji W
Thorac Cancer; 2019 Oct; 10(10):1885-1892. PubMed ID: 31389192
[TBL] [Abstract][Full Text] [Related]
13. Elevation of serum procalcitonin in patients after chemical pleurodesis with intrapleural injection of OK-432.
Xu BL; Yu JQ; Tang KJ; Liu DY; Kuang YK
Clin Respir J; 2014 Jan; 8(1):41-4. PubMed ID: 23711195
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic and life-prolonging effect of intrapleural injection with a streptococcal preparation, OK-432, and IL2-cultured effusion lymphocytes to breast cancer patients with malignant pleural effusion.
Hori T; Mise K; Kan N; Okino T; Satoh K; Yamasaki S; Teramura Y; Harada T; Ohgaki K; Kodama H
Biotherapy; 1992; 5(1):21-9. PubMed ID: 1389900
[TBL] [Abstract][Full Text] [Related]
15. Intrapleural chemo- and hyperthermotherapies for malignant pleural effusion: a randomized prospective study.
Chen WJ; Yuan SF; Yan QY; Xiong JP; Wang SM; Zheng WE; Zhang W; Sun HY; Chen H; Wu LL
Cancer Invest; 2012 Feb; 30(2):126-30. PubMed ID: 22148972
[TBL] [Abstract][Full Text] [Related]
16. Pleural effusion as a significant prognostic factor in non-small cell lung cancer.
Naito T; Satoh H; Ishikawa H; Yamashita YT; Kamma H; Takahashi H; Ohtsuka M; Hasegawa S
Anticancer Res; 1997; 17(6D):4743-6. PubMed ID: 9494600
[TBL] [Abstract][Full Text] [Related]
17. Intracavitary injection of OK-432 for malignant pericardial effusion, a case report.
Nanjo T
Radiat Med; 1990; 8(4):155-8. PubMed ID: 2281151
[TBL] [Abstract][Full Text] [Related]
18. [Intrapleural administration with OK-432 and cultured autologous pleural effusion lymphocytes for breast cancer patients with malignant pleural effusions: analysis of 84 patients over a 14-year period].
Kan N
Gan To Kagaku Ryoho; 1999 Oct; 26(12):1796-800. PubMed ID: 10560397
[TBL] [Abstract][Full Text] [Related]
19. Management of malignant pleural effusion by suicide gene therapy in advanced stage lung cancer: a case series and literature review.
Zarogoulidis P; Chatzaki E; Hohenforst-Schmidt W; Goldberg EP; Galaktidou G; Kontakiotis T; Karamanos N; Zarogoulidis K
Cancer Gene Ther; 2012 Sep; 19(9):593-600. PubMed ID: 22744209
[TBL] [Abstract][Full Text] [Related]
20. A new fetal therapy for chylothorax: pleurodesis with OK-432.
Okawa T; Takano Y; Fujimori K; Yanagida K; Sato A
Ultrasound Obstet Gynecol; 2001 Oct; 18(4):376-7. PubMed ID: 11778999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
